3rd Quarter - Report
ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.
Firm
Client
Income
—
Expenses
$147,775
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent reform, HR 1249 and S 23
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
| WHITNEY TULL | — |
Trade (domestic/foreign) TRD
KORUS FTA
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
Health Issues HCR
FDA 510k reform and Medical Device User Fees and PPACA (health care law) implementation and Musculoskeletal Health Disparties Summit in D.C.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
| WHITNEY TULL | — |
Taxation/Internal Revenue Code TAX
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
| WHITNEY TULL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.